Forte Biosciences Inc (FBRX NASDAQ) stock market data APIs
$20.1938
0.36(1.8%)
as of May 20, 2026
Try our APIs with
free plan!
Forte Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Prev. Close
20.1938
Open
20.5488
High
21.026
Low
19.6739
52 wk Range
7.78-35.8
Market Cap
411 M
Shares Outstanding
20 479 K
EPS
-1.24
Beta
3.005
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Forte Biosciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Forte Biosciences Inc data using free add-ons & libraries
Get Forte Biosciences Inc Fundamental Data
Forte Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -76 902 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -1.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Forte Biosciences Inc News
New
Top Midday Gainers
Ares Management (ARES) on Thursday agreed to acquire real estate investment trust Whitestone REIT (W PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
After-Hours Gainers: GH Research, Phathom, Forte, OKYO, Zai Lab, LifeMD, Werewolf & Corvus Rally
(RTTNews) - Biotech names dominated the after-hours session on Friday, with several companies posting notable gains despite limited news catalysts. GH Research PLC (GHRS) surged the most, climbing 22...
Forte Biosciences Tops Q2 Loss Forecasts
Key Points GAAP EPS loss of $(0.96) beat analyst expectations for Q2 2025, driven by lower general and administrative expenses. reflecting increased clinical trial activity for lead product FB102. Fo...
Forte Biosciences stock falls after pricing capital raise of $75M via securities offering
Forte Biosciences (NASDAQ:FBRX [https://seekingalpha.com/symbol/FBRX]) has announced the pricing [https://seekingalpha.com/pr/20146901-forte-biosciences-announces-pricing-of-75-million-public-offering...
Get Forte Biosciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
